36 filings
8-K
RLAY
Relay Therapeutics Inc
22 Feb 24
Relay Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Highlights
4:10pm
8-K
RLAY
Relay Therapeutics Inc
8 Jan 24
Entry into a Material Definitive Agreement
7:05am
8-K
RLAY
Relay Therapeutics Inc
2 Nov 23
Relay Therapeutics Reports Third Quarter 2023 Financial Results and Corporate Highlights
4:10pm
8-K
RLAY
Relay Therapeutics Inc
12 Oct 23
Relay Therapeutics Announces Initial RLY-4008 (lirafugratinib) Data Demonstrating Durable Responses Across Multiple FGFR2-Altered Solid Tumors
4:13pm
8-K
RLAY
Relay Therapeutics Inc
8 Aug 23
Relay Therapeutics Reports Second Quarter 2023 Financial Results and Corporate Highlights
4:14pm
8-K
k9zp04q9fprwbo
31 May 23
Submission of Matters to a Vote of Security Holders
4:05pm
8-K
rtvllgq0uqt94vaf
25 May 23
Relay Therapeutics Announces Full Dose Escalation Data for RLY-4008
5:05pm
8-K
1rmapw6zpd4nxgv0ou7
4 May 23
Relay Therapeutics Reports First Quarter 2023 Financial Results and Corporate Highlights
4:10pm
8-K
24hy84
18 Apr 23
Regulation FD Disclosure
10:42am
8-K
kyvawbp4
23 Feb 23
Relay Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Corporate Highlights
4:11pm
8-K
a6h7mrfw8d3 hs7
9 Jan 23
JPM Presentation January 2023
7:01am
8-K
z8pokup
3 Nov 22
Relay Therapeutics Reports Third Quarter 2022 Financial Results and Corporate Highlights
4:11pm
8-K
03jzvpx 7f7o
15 Sep 22
Relay Therapeutics Announces Proposed Public Offering of Common Stock
6:33am
8-K
cjxsb5ex
12 Sep 22
Enrollment for the pivotal cohort anticipated to be completed in the second half of 2023
6:05am
8-K
h4dceqq6y 7xrks5cf8
8 Sep 22
Regulation FD Disclosure
6:31am
8-K
trss9tz3gr4a9nwb
4 Aug 22
Relay Therapeutics Reports Second Quarter 2022 Financial Results and Corporate Highlights
4:32pm
8-K
4xr8frdjbmy2nsimrb7
27 Jul 22
Departure of Directors or Certain Officers
8:01am
8-K
pzn38d65tgqt6wu58omq
27 Jun 22
Regulation FD Disclosure
6:11am
8-K
6w05 h0udfpv62he5
27 May 22
Amendments to Articles of Incorporation or Bylaws
4:37pm
8-K
3udbo4 6dhwj4
5 May 22
Relay Therapeutics Reports First Quarter 2022 Financial Results and Corporate Highlights
12:00am